Clinical Trial Update: Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating topical ABI-1968 in subjects with precancerous anal lesions caused by HPV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• HIV Infection
• High-grade Squamous Intraepithelial Lesion
• Human Papillomavirus Infection

Drugs mentioned

• ABI-1968 (Topical ABI-1968)

Snippet

Sponsor: Antiva Biosciences | Conditions: HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection | Phase 1 | Status: COMPLETED